About this trial
This study aims to determine which type of distal arteriovenous fistula (SBAVF, RCAVF, and RCAVF with venous branch patch) is most clinically favorable.
The recommendations and scientific evidence do not suggest which option should be chosen initially.
The investigators expect that results will show which type of the anastomosis should be preferred.
Eligibility criteria
Qualifiers
Aged >18 years
Chronic kidney disease with estimated glomerular filtration rate (eGFR) <20 mL/min/1.73 m2
Disqualifiers
Heart failure of New York Heart Association functional class III or IV,
Episode of cardio- or cerebrovascular event or receiving intervention therapy within 3 months prior to screening.
The patient had the primary anastomosis in the past on ipsilateral extremity
Trial design
Treatments tested in this trial
- AVF
Treatment groups
Locations
1Sponsors and collaborators
Wroclaw Medical University
Lead sponsor